Clinigene International, a subsidiary of Biocon, and Pacific Biomarkers, a Seattle-Washington based company, has announced a collaborative agreement to address the speciality biomarker and high-end clinical trial laboratory needs of the global pharmaceutical and biotech industry.
Commenting on the partnership, Mr Peter Bains, Biocon’s director of research services business, said Pacific Biomarkers is a recognised leader in providing speciality biomarkers and clinical diagnostic assay services to discovery and development-based life science enterprises.
“We are delighted that the company has selected Clinigene as its partner in India and we look forward to supporting Pacific Biomarkers in extending and expanding its speciality services offering,” he said.